SIMPLEX TRADING, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2023$7
+40.0%
14,110
+54.6%
0.00%
Q1 2023$5
-83.9%
9,128
-81.0%
0.00%
Q4 2022$31
-99.9%
47,932
+180.5%
0.00%
Q3 2022$29,000
+16.0%
17,090
-17.5%
0.00%
Q2 2022$25,000
-47.9%
20,724
-72.3%
0.00%
Q1 2022$48,000
+37.1%
74,692
+129.3%
0.00%
Q4 2021$35,000
-85.6%
32,571
-63.5%
0.00%
Q3 2021$243,000
+3.4%
89,3170.0%0.00%
Q2 2021$235,000
-21.4%
89,317
+7.3%
0.00%
-100.0%
Q1 2021$299,000
+190.3%
83,228
+102.3%
0.00%
Q4 2020$103,000
-9.6%
41,138
-9.5%
0.00%
Q3 2020$114,000
-55.6%
45,459
-42.1%
0.00%
Q2 2020$257,000
+127.4%
78,446
+69.5%
0.00%
Q1 2020$113,000
-39.2%
46,292
+16.9%
0.00%
Q4 2019$186,000
+365.0%
39,596
+323.5%
0.00%
Q3 2019$40,000
-86.5%
9,349
-81.6%
0.00%
-100.0%
Q2 2019$296,000
+88.5%
50,810
+24.5%
0.00%
Q1 2019$157,000
+141.5%
40,814
+17.2%
0.00%
Q4 2018$65,000
-68.0%
34,819
-45.3%
0.00%
-100.0%
Q3 2018$203,000
+4.6%
63,685
-1.0%
0.00%0.0%
Q2 2018$194,000
-43.1%
64,335
-26.2%
0.00%
-93.3%
Q1 2018$341,000
+244.4%
87,230
+261.6%
0.02%
+275.0%
Q4 2017$99,000
-48.7%
24,122
-23.6%
0.00%
-50.0%
Q3 2017$193,000
+77.1%
31,572
+82.0%
0.01%
+60.0%
Q1 2017$109,000
-32.3%
17,344
-42.4%
0.01%
-50.0%
Q4 2016$161,000
+94.0%
30,094
+103.7%
0.01%
+66.7%
Q3 2016$83,000
-70.1%
14,774
-70.9%
0.01%
-68.4%
Q2 2016$278,000
+146.0%
50,713
+230.2%
0.02%
+111.1%
Q1 2016$113,000
-74.8%
15,360
-71.6%
0.01%
-74.3%
Q4 2015$449,000
+40.3%
54,068
+52.1%
0.04%
+52.2%
Q3 2015$320,000
+370.6%
35,558
+523.1%
0.02%
+283.3%
Q2 2015$68,0005,7070.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders